Predicting skin permeability from complex vehicles.
暂无分享,去创建一个
Jim E Riviere | Daniela Karadzovska | Nancy A Monteiro-Riviere | N. Monteiro-Riviere | J. Riviere | James D Brooks | J. Brooks | D. Karadzovska
[1] J. Hadgraft,et al. Dermal delivery of selected hydrophilic drugs from elastic liposomes: effect of phospholipid formulation and surfactants , 2007, The Journal of pharmacy and pharmacology.
[2] Bernard Testa,et al. Quantitative Structure-Permeation Relationships (QSPeRs) to Predict Skin Permeation: A Critical Evaluation , 2004, Pharmaceutical Research.
[3] B. Röder,et al. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[4] R H Guy,et al. Skin penetration and distribution of polymeric nanoparticles. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[5] J. Lademann,et al. Hair Follicles – A Long-Term Reservoir for Drug Delivery , 2006, Skin Pharmacology and Physiology.
[6] B. Magnusson,et al. The effects of vehicle and region of application on in vitro penetration of testosterone through canine skin. , 2006, Veterinary journal.
[7] N. Monteiro-Riviere,et al. An experimentally based approach for predicting skin permeability of chemicals and drugs using a membrane-coated fiber array. , 2007, Toxicology and applied pharmacology.
[8] F. Stracke,et al. Influence of Nanoencapsulation on Human Skin Transport of Flufenamic Acid , 2006, Skin Pharmacology and Physiology.
[9] R. Bronaugh,et al. Methods for in vitro percutaneous absorption studies IV: The flow-through diffusion cell. , 1985, Journal of pharmaceutical sciences.
[10] B. W. Barry,et al. CHEMICAL PENETRATION ENHANCEMENT : POSSIBILITIES AND PROBLEMS , 1998 .
[11] P. Williams,et al. The use of mechanistically defined chemical mixtures (MDCM) to assess mixture component effects on the percutaneous absorption and cutaneous disposition of topically exposed chemicals. II. Development of a general dermatopharmacokinetic model for use in risk assessment. , 1996, Toxicology and Applied Pharmacology.
[12] Jim E. Riviere,et al. COMPASS PLOTS: A COMBINATION OF STAR PLOT AND ANALYSIS OF MEANS TO VISUALIZE SIGNIFICANT INTERACTIONS IN COMPLEX TOXICOLOGY STUDIES , 2000 .
[13] P. Williams,et al. The use of mechanistically defined chemical mixtures (MDCM) to assess component effects on the percutaneous absorption and cutaneous disposition of topically exposed chemicals. I. Studies with parathion mixtures in isolated perfused porcine skin. , 1996, Toxicology and Applied Pharmacology.
[14] A. Naik,et al. In vivo infrared spectroscopy studies of alkanol effects on human skin. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[15] H. Trommer,et al. Overcoming the Stratum Corneum: The Modulation of Skin Penetration , 2006, Skin Pharmacology and Physiology.
[16] W. Sterry,et al. Determination of the cuticula thickness of human and porcine hairs and their potential influence on the penetration of nanoparticles into the hair follicles. , 2009, Journal of biomedical optics.
[17] T. Ghafourian,et al. The effect of structural QSAR parameters on skin penetration. , 2001, International journal of pharmaceutics.
[18] R. Scheuplein,et al. Mechanism of percutaneous absorption. V. Percutaneous absorption of solvent deposited solids. , 1974, The Journal of investigative dermatology.
[19] H. Yardley. Epidermal lipids , 1987, International journal of cosmetic science.
[20] J E Riviere,et al. Modelling the effect of mixture components on permeation through skin. , 2010, International journal of pharmaceutics.
[21] Mads Kreilgaard,et al. Influence of microemulsions on cutaneous drug delivery. , 2002, Advanced drug delivery reviews.
[22] G. Storm,et al. Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times. , 1993, Biochimica et biophysica acta.
[23] S. Yalkowsky,et al. Correlation and prediction of mass transport across membranes. I. Influence of alkyl chain length on flux-determining properties of barrier and diffusant. , 1972, Journal of pharmaceutical sciences.
[24] G. Cevc,et al. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. , 1992, Biochimica et biophysica acta.
[25] Shozo Miyazaki,et al. Poly n-butylcyanoacrylate (PNBCA) nanocapsules as a carrier for NSAIDs: in vitro release and in vivo skin penetration. , 2003, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[26] R H Guy,et al. Prediction of chemical absorption into and through the skin from cosmetic and dermatological formulations , 2009, The British journal of dermatology.
[27] G. Cevc,et al. Biological activity and characteristics of triamcinolone-acetonide formulated with the self-regulating drug carriers, Transfersomes. , 2003, Biochimica et biophysica acta.
[28] Michael S. Roberts,et al. Dermal Absorption and Toxicity Assessment , 2007 .
[29] A. Costache,et al. Percutaneous penetration modifiers and formulation effects. , 2010, International journal of pharmaceutics.
[30] B. Godin,et al. Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[31] José Blanco-Méndez,et al. Delivery of a hydrophilic solute through the skin from novel microemulsion systems , 1997 .
[32] Membrane-coated fiber array approach for predicting skin permeability of chemical mixtures from different vehicles. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[33] S. Reiz,et al. EMLA ‐ a Eutectic Mixture of Local Anaesthetics for Topical Anaesthesia , 1982, Acta anaesthesiologica Scandinavica.
[34] J. Hadgraft,et al. Vehicle effect on topical drug delivery. III. Effect of Azone on the cutaneous permeation of metronidazole and propylene glycol , 1985 .
[35] L. Norlén. Molecular Skin Barrier Models and Some Central Problems for the Understanding of Skin Barrier Structure and Function , 2003, Skin Pharmacology and Physiology.
[36] M. Mumtaz,et al. Effect of chemical interactions in pentachlorophenol mixtures on skin and membrane transport. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.
[37] B. Lippold,et al. Percutaneous penetration enhancement and its quantification. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[38] N. Monteiro-Riviere,et al. A Novel in-Vitro Technique for Studying Percutaneous Permeation with a Membrane-Coated Fiber and Gas Chromatography/Mass Spectrometry: Part I. Performances of the Technique and Determination of the Permeation Rates and Partition Coefficients of Chemical Mixtures , 2003, Pharmaceutical Research.
[39] M. Mumtaz,et al. Mixture component effects on the in vitro dermal absorption of pentachlorophenol , 2001, Archives of Toxicology.
[40] William W. Yu,et al. Biological interactions of quantum dot nanoparticles in skin and in human epidermal keratinocytes. , 2008, Toxicology and applied pharmacology.
[41] E. Touitou,et al. Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. , 2000, Biomaterials.
[42] B. Møllgaard,et al. Vehicle effect on topical drug delivery. II. Concurrent skin transport of drugs and vehicle components. , 1983, Acta pharmaceutica Suecica.
[43] J. Hadgraft,et al. Effect of Penetration Modifiers on the Dermal and Transdermal Delivery of Drugs and Cosmetic Active Ingredients , 2008, Skin Pharmacology and Physiology.
[44] M. Schaller,et al. Drug Targeting by Solid Lipid Nanoparticles for Dermal Use , 2002, Journal of drug targeting.
[45] T E McKone,et al. Estimating skin permeation. The validation of five mathematical skin permeation models. , 1995, Chemosphere.
[46] J. Lévêque,et al. Organization of Stratum Corneum Lipids in Relation to Permeability: Influence of Sodium Lauryl Sulfate and Preheating , 1994, Pharmaceutical Research.
[47] B. Baroli,et al. Penetration of nanoparticles and nanomaterials in the skin: fiction or reality? , 2010, Journal of pharmaceutical sciences.
[48] H. Mukhtar. Pharmacology of the skin , 1992 .
[49] M. Schäfer-Korting,et al. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[50] Marc Schneider,et al. Nanoparticles and their interactions with the dermal barrier , 2009, Dermato-endocrinology.
[51] J. Hadgraft,et al. Probing the Effect of Vehicles on Topical Delivery: Understanding the Basic Relationship Between Solvent and Solute Penetration Using Silicone Membranes , 2004, Pharmaceutical Research.
[52] N. Monteiro-Riviere,et al. Comparative In Vivo Toxicity of Topical JP-8 Jet Fuel and Its Individual Hydrocarbon Components: Identification of Tridecane and Tetradecane as Key Constituents Responsible for Dermal Irritation , 2005, Toxicologic pathology.
[53] A. Ohkawara. [Structure and function of the skin]. , 1983, Iyo denshi to seitai kogaku. Japanese journal of medical electronics and biological engineering.
[54] R. Guy,et al. The effects of zwitterionic surfactants on skin barrier function. , 1991, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[55] J. Riviere,et al. Membrane transport of naphthalene and dodecane in jet fuel mixtures , 2000 .
[56] Y. Kalia,et al. Enhanced skin permeation of a lipophilic drug using supersaturated formulations. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[57] P. Elias,et al. Epidermal lipids, barrier function, and desquamation. , 1983, The Journal of investigative dermatology.
[58] Jessica P. Ryman-Rasmussen,et al. Dermal Effects of Nanomaterials , 2007 .
[59] T M Morgan,et al. Transdermal penetration enhancers: applications, limitations, and potential. , 1999, Journal of pharmaceutical sciences.
[60] S. Mitragotri,et al. Enhancement of transdermal drug delivery via synergistic action of chemicals. , 2009, Biochimica et biophysica acta.
[61] C. I. Bliss. THE TOXICITY OF POISONS APPLIED JOINTLY1 , 1939 .
[62] Russell O. Potts,et al. Predicting Skin Permeability , 1992, Pharmaceutical Research.
[63] I. M. Raigorodskii,et al. Modeling of percutaneous drug transport in vitro using skin-imitating Carbosil membrane. , 1998, Journal of Controlled Release.
[64] M. Roberts,et al. Effect of Ion Pairing with Alkylamines on the In‐vitro Dermal Penetration and Local Tissue Disposition of Salicylates , 2000, The Journal of pharmacy and pharmacology.
[65] N. Monteiro-Riviere,et al. A system coefficient approach for quantitative assessment of the solvent effects on membrane absorption from chemical mixtures , 2007, SAR and QSAR in environmental research.
[66] M. Abraham,et al. Human skin permeation and partition: general linear free-energy relationship analyses. , 2004, Journal of pharmaceutical sciences.
[67] N el Tayar,et al. Percutaneous penetration of drugs: a quantitative structure-permeability relationship study. , 1991, Journal of pharmaceutical sciences.
[68] Y. Chevalier,et al. Nanoparticles through the skin: managing conflicting results of inorganic and organic particles in cosmetics and pharmaceutics. , 2011, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[69] J. Hadgraft,et al. Percutaneous absorption: in vivo experiments , 1979, The Journal of pharmacy and pharmacology.
[70] J. Hadgraft,et al. Effect of finite doses of propylene glycol on enhancement of in vitro percutaneous permeation of loperamide hydrochloride. , 2004, International journal of pharmaceutics.
[71] K. A. Walters,et al. Dermatological And Transdermal Formulations , 2002 .
[72] Taravat Ghafourian,et al. Validated models for predicting skin penetration from different vehicles. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[73] N. Monteiro-Riviere,et al. The isolated perfused porcine skin flap as an in vitro model for percutaneous absorption and cutaneous toxicology. , 1991, Critical reviews in toxicology.
[74] R. Guy,et al. Mechanism of percutaneous penetration enhancement : effect of n-alkanols on the permeability barrier of hairless mouse skin , 1990 .
[75] J. Hadgraft,et al. Effect of Vehicle Pretreatment on the Flux, Retention, and Diffusion of Topically Applied Penetrants in Vitro , 2003, Pharmaceutical Research.
[76] M. Roberts,et al. Ion‐pair Formation as a Strategy to Enhance Topical Delivery of Salicylic Acid , 2000, The Journal of pharmacy and pharmacology.
[77] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[78] Eric W. Smith,et al. The Vehicle: The Pharmaceutical Carrier of Dermatological Agents , 2000 .
[79] Ivan Gutman,et al. WIENER-TYPE TOPOLOGICAL INDICES , 1998 .
[80] Bradley D. Anderson,et al. The Role of Protein and Lipid Domains in the Uptake of Solutes by Human Stratum Corneum , 1988, Pharmaceutical Research.
[81] A. Schätzlein,et al. TRANSDERMAL DRUG CARRIERS - BASIC PROPERTIES, OPTIMIZATION AND TRANSFER EFFICIENCY IN THE CASE OF EPICUTANEOUSLY APPLIED PEPTIDES , 1995 .
[82] M. Roberts,et al. Human Skin Penetration of Sunscreen Nanoparticles: In-vitro Assessment of a Novel Micronized Zinc Oxide Formulation , 2007, Skin Pharmacology and Physiology.
[83] Adrian C. Williams,et al. Penetration enhancers. , 2004, Advanced drug delivery reviews.
[84] H. Korting,et al. Lipid nanoparticles for improved topical application of drugs for skin diseases. , 2007, Advanced drug delivery reviews.
[85] R. Guy,et al. Biodegradable polymer nanocapsules containing a sunscreen agent: preparation and photoprotection. , 2001, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[86] J. Riviere,et al. Predicting skin permeability from complex chemical mixtures. , 2005, Toxicology and applied pharmacology.
[87] Majella E Lane,et al. Skin penetration enhancers. , 2013, International journal of pharmaceutics.
[88] Brian E. Kilfoyle,et al. Percutaneous permeation modifiers: enhancement versus retardation. , 2008, Expert opinion on drug delivery.
[89] B. Poulsen. Design of Topical Drug Products: Biopharmaceutics , 1973 .
[90] Samir Mitragotri,et al. Design principles of chemical penetration enhancers for transdermal drug delivery. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[91] R. Stoughton,et al. Correlation of the vasoconstriction assay and clinical activity in psoriasis. , 1985, Archives of dermatology.
[92] T. Luger,et al. Evidence for an epidermal cytokine network. , 1990, The Journal of investigative dermatology.
[93] E. R. Garrett,et al. Evaluation, control, and prediction of drug diffusion through polymeric membranes. I. Methods and reproducibility of steady-state diffusion studies. , 1968, Journal of pharmaceutical sciences.
[94] F. Nielsen,et al. Dermal in vitro penetration of methiocarb, paclobutrazol, and pirimicarb , 2000, Occupational and environmental medicine.
[95] A. Bunge,et al. A New Method for Estimating Dermal Absorption from Chemical Exposure. 3. Compared with Steady-State Methods for Prediction and Data Analysis , 1995, Pharmaceutical Research.
[96] B. W. Barry,et al. Novel mechanisms and devices to enable successful transdermal drug delivery. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[97] Mark T D Cronin,et al. Quantitative structure-permeability relationships for percutaneous absorption: re-analysis of steroid data. , 2002, International journal of pharmaceutics.
[98] Michael H. Abraham,et al. The Factors that Influence Skin Penetration of Solutes * , 1995 .
[99] F. Flowers,et al. Use of solubility parameters of drug and vehicle to predict flux through skin. , 1986, The Journal of investigative dermatology.
[100] Thomas Kuhlbusch,et al. Particle and Fibre Toxicology BioMed Central Review The potential risks of nanomaterials: a review carried out for ECETOC , 2006 .
[101] P. Elias,et al. Lipids and the epidermal water barrier: metabolism, regulation, and pathophysiology. , 1992, Seminars in dermatology.
[102] M. Roberts,et al. Water. The most natural penetration enhancer , 1993 .
[103] N. Monteiro-Riviere,et al. Pyridostigmine bromide modulates the dermal disposition of [14C]permethrin. , 2002, Toxicology and applied pharmacology.
[104] G. E. El Maghraby,et al. Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes. , 2004, International journal of pharmaceutics.
[105] R. Scheuplein,et al. Mechanism of percutaneous absorption. IV. Penetration of nonelectrolytes (alcohols) from aqueous solutions and from pure liquids. , 1973, The Journal of investigative dermatology.
[106] J. Riviere,et al. Dermal Chemical Mixtures , 2010 .
[107] De Bary,et al. Comparative Anatomy , 1838, Nature.
[108] L. Norlén,et al. Skin barrier structure and function: the single gel phase model. , 2001, The Journal of investigative dermatology.
[109] M. Katz. Chapter 4 – Design of Topical Drug Products: Pharmaceutics , 1973 .
[110] R. Müller,et al. Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[111] D. van der Merwe,et al. Comparative studies on the effects of water, ethanol and water/ethanol mixtures on chemical partitioning into porcine stratum corneum and silastic membrane. , 2005, Toxicology in vitro : an international journal published in association with BIBRA.
[112] A. Bunge,et al. A New Method for Estimating Dermal Absorption from Chemical Exposure: 2. Effect of Molecular Weight and Octanol-Water Partitioning , 2004, Pharmaceutical Research.
[113] T. Franz. Percutaneous absorption on the relevance of in vitro data. , 1975, The Journal of investigative dermatology.
[114] Norman Weiner,et al. Validation of a Flow-Through Diffusion Cell for Use in Transdermal Research , 1987, Pharmaceutical Research.
[115] N. Monteiro-Riviere,et al. Penetration of intact skin by quantum dots with diverse physicochemical properties. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[116] J. Hadgraft,et al. Recent developments in topical and transdermal delivery , 1996, European Journal of Drug Metabolism and Pharmacokinetics.
[117] S. Agatonovic-Kustrin,et al. ANN modeling of the penetration across a polydimethylsiloxane membrane from theoretically derived molecular descriptors. , 2001, Journal of pharmaceutical and biomedical analysis.
[118] C. Brownie,et al. In vitro percutaneous absorption of benzidine in complex mechanistically defined chemical mixtures. , 1996, Toxicology and applied pharmacology.
[119] Claus-Michael Lehr,et al. Nanoparticles--an efficient carrier for drug delivery into the hair follicles. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[120] R. Müller,et al. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. , 2002, Advanced drug delivery reviews.
[121] R. Guy,et al. Physicochemical Aspects of Percutaneous Penetration and Its Enhancement , 1988, Pharmaceutical Research.
[122] S. Schulte,et al. Safety evaluation of sunscreen formulations containing titanium dioxide and zinc oxide nanoparticles in UVB sunburned skin: an in vitro and in vivo study. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.
[123] J. Riviere,et al. Predicting skin permeability from complex chemical mixtures: dependency of quantitative structure permeation relationships on biology of skin model used. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.
[124] Robert Langer,et al. Transdermal drug delivery , 2008, Nature Biotechnology.
[125] A. Nokhodchi,et al. The effect of surfactants on the skin penetration of diazepam. , 2001, International journal of pharmaceutics.
[126] Nissim Garti,et al. Microemulsions as transdermal drug delivery vehicles. , 2006, Advances in colloid and interface science.
[127] M. Manfait,et al. An in vivo Randomized Study of Human Skin Moisturization by a New Confocal Raman Fiber-Optic Microprobe: Assessment of a Glycerol-Based Hydration Cream , 2006, Skin Pharmacology and Physiology.
[128] S. Wilkinson,et al. The influence of water mixtures on the dermal absorption of glycol ethers. , 2007, Toxicology and applied pharmacology.
[129] P. Williams,et al. Pharmacokinetic implications of changing blood flow in skin. , 1992, Journal of pharmaceutical sciences.
[130] J. Riviere. Percutaneous Absorption of Complex Chemical Mixtures , 2004 .
[131] E. Morgan. Regulation of cytochrome p450 by inflammatory mediators: why and how? , 2001, Drug metabolism and disposition: the biological fate of chemicals.
[132] T L Kurt,et al. Neurotoxicity resulting from coexposure to pyridostigmine bromide, deet, and permethrin: implications of Gulf War chemical exposures. , 1996, Journal of toxicology and environmental health.
[133] J. Hadgraft,et al. Optimisation of Cosolvent Concentration for Topical Drug Delivery III – Influence of Lipophilic Vehicles on Ibuprofen Permeation , 2010, Skin Pharmacology and Physiology.
[134] S. Kakar,et al. TRANSDERMAL DRUG DELIVERY AS A BOON , 2014 .
[135] N. Monteiro-Riviere,et al. Identification of early biomarkers of inflammation produced by keratinocytes exposed to jet fuels jet A, JP‐8, and JP‐8(100) , 2000, Journal of biochemical and molecular toxicology.
[136] N. Monteiro-Riviere,et al. Gulf War related exposure factors influencing topical absorption of 14C-permethrin. , 2002, Toxicology letters.
[137] B. Forslind. A domain mosaic model of the skin barrier. , 1994, Acta dermato-venereologica.
[138] Jim E. Riviere,et al. Interaction of nanomaterials with skin: Aspects of absorption and biodistribution , 2009 .
[139] Mark R Prausnitz,et al. Transdermal delivery enhanced by magainin pore-forming peptide. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[140] R. Neubert,et al. Microemulsions--modern colloidal carrier for dermal and transdermal drug delivery. , 2008, Journal of pharmaceutical sciences.
[141] R. Bronaugh,et al. Extent of cutaneous metabolism during percutaneous absorption of xenobiotics. , 1989, Toxicology and applied pharmacology.
[142] M. Hussain,et al. Contributions of Drug Solubilization, Partitioning, Barrier Disruption, and Solvent Permeation to the Enhancement of Skin Permeation of Various Compounds with Fatty Acids and Amines , 1990, Pharmaceutical Research.
[143] J. Riviere,et al. Quantification of chemical mixture interactions modulating dermal absorption using a multiple membrane fiber array. , 2008, Chemical research in toxicology.
[144] L. Rodrigues,et al. Solvent effects in permeation assessed in vivo by skin surface biopsy , 2003, BMC dermatology.
[145] A. Michaels,et al. Drug permeation through human skin: Theory and invitro experimental measurement , 1975 .
[146] R. Guy,et al. Disposition of Charged Nanoparticles after Their Topical Application to the Skin , 2009, Skin Pharmacology and Physiology.
[147] N. Monteiro-Riviere,et al. Pyridostigmine bromide modulates topical irritant-induced cytokine release from human epidermal keratinocytes and isolated perfused porcine skin. , 2003, Toxicology.
[148] R. Guy,et al. Disposition of nanoparticles and an associated lipophilic permeant following topical application to the skin. , 2009, Molecular pharmaceutics.
[149] J. Hadgraft,et al. Optimisation of Cosolvent Concentration for Topical Drug Delivery – II: Influence of Propylene Glycol on Ibuprofen Permeation , 2009, Skin Pharmacology and Physiology.
[150] N. Monteiro-Riviere,et al. Dermatotoxicity of Cutting Fluid Mixtures:In Vitro and In Vivo Studies , 2006, Cutaneous and ocular toxicology.
[151] J. Riviere,et al. Surfactant Effects on Skin Absorption of Model Organic Chemicals: Implications for Dermal Risk Assessment Studies , 2010, Journal of toxicology and environmental health. Part A.
[152] R. Guy,et al. Drug Delivery to the Skin From Sub-micron Polymeric Particle Formulations: Influence of Particle Size and Polymer Hydrophobicity , 2009, Pharmaceutical Research.
[153] P. Wertz,et al. Effect of Selective Lipid Extraction from Different Body Regions on Epidermal Barrier Function , 2001, Pharmaceutical Research.
[154] J. Kreuter,et al. Effect of nonionic surfactants on transdermal drug delivery: I. Polysorbates , 1991 .
[155] S. Oldenburg,et al. Evaluation of Silver Nanoparticle Toxicity in Skin in Vivo and Keratinocytes in Vitro , 2009, Environmental health perspectives.
[156] R. Brand,et al. Transdermal penetration of atrazine, alachlor, and trifluralin: effect of formulation. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.
[157] P. Wertz,et al. Molecular models of the intercellular lipid lamellae in mammalian stratum corneum. , 1989, The Journal of investigative dermatology.
[158] J. Hadgraft,et al. Application of Microemulsions in Dermal and Transdermal Drug Delivery , 2008, Skin Pharmacology and Physiology.
[159] N. Monteiro-Riviere,et al. Dermal Exposure and Absorption of Chemicals and Nanomaterials , 2010 .
[160] B. Idson. Vehicle effects in percutaneous absorption. , 1983, Drug metabolism reviews.
[161] Yanjun Zhao,et al. The role of vehicle-nanoparticle interactions in topical drug delivery. , 2010, International journal of pharmaceutics.
[162] B. W. Barry,et al. Action of penetration enhancers on human skin as assessed by the permeation of model drugs 5-fluorouracil and estradiol. I. Infinite dose technique. , 1988, The Journal of investigative dermatology.
[163] J. Bouwstra,et al. Structure of the skin barrier and its modulation by vesicular formulations. , 2003, Progress in lipid research.
[164] H. Beall,et al. Topical delivery of 5-fluorouracil (5-Fu) by 3-alkylcarbonyl-5-Fu prodrugs. , 2001, International journal of pharmaceutics.
[165] Wolfgang Becker,et al. Nanoparticles and microparticles for skin drug delivery. , 2011, Advanced drug delivery reviews.
[166] D. van der Merwe,et al. Effect of vehicles and sodium lauryl sulphate on xenobiotic permeability and stratum corneum partitioning in porcine skin. , 2005, Toxicology.
[167] S. Yalkowsky,et al. Correlation and prediction of mass transport across membranes. II. Influence of vehicle polarity on flux from solutions and suspensions. , 1974, Journal of pharmaceutical sciences.
[168] J. Jaroszewski,et al. NMR characterisation and transdermal drug delivery potential of microemulsion systems. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[169] Michael H. Abraham,et al. Hydrogen bonding part 46: a review of the correlation and prediction of transport properties by an lfer method: physicochemical properties, brain penetration and skin permeability , 1999 .
[170] J. Riviere. Dermal Absorption Models in Toxicology and Pharmacology , 2005 .
[171] P. Elias,et al. Percutaneous transport in relation to stratum corneum structure and lipid composition. , 1981, The Journal of investigative dermatology.
[172] J. Ostrenga,et al. Significance of vehicle composition. II. Prediction of optimal vehicle composition. , 1971, Journal of pharmaceutical sciences.
[173] R. Guy,et al. Influence of Ethanol on the Solubility, Ionization and Permeation Characteristics of Ibuprofen in Silicone and Human Skin , 2008, Skin Pharmacology and Physiology.
[174] H. Benson,et al. Ion‐pairs of ibuprofen: increased membrane diffusion , 2004, The Journal of pharmacy and pharmacology.
[175] F. Levi-Schaffer,et al. Intracellular delivery mediated by an ethosomal carrier. , 2001, Biomaterials.
[176] R. Scheuplein,et al. Mechanism of percutaneous absorption. 3. The effect of temperature on the transport of non-electrolytes across the skin. , 1967, The Journal of investigative dermatology.
[177] A. Williamsd,et al. Liposomes and skin : From drug delivery to model membranes , 2008 .
[178] J. Ostrenga,et al. Significance of vehicle composition. I. Relationship between topical vehicle composition, skin penetrability, and clinical efficacy. , 1971, Journal of pharmaceutical sciences.
[179] J. Kreuter,et al. Effect of nonionic surfactants on transdermal drug delivery: II. Poloxamer and poloxamine surfactants , 1991 .
[180] J. Riviere,et al. Prediction of dermal absorption from complex chemical mixtures: incorporation of vehicle effects and interactions into a QSPR framework , 2007, SAR and QSAR in environmental research.
[181] R. Scheuplein,et al. Permeability of the skin. , 1971, Physiological reviews.
[182] Hatem Fessi,et al. Topical delivery of cosmetics and drugs. Molecular aspects of percutaneous absorption and delivery. , 2009, European journal of dermatology : EJD.
[183] P. Elias,et al. Epidermal lipids, barrier function, and desquamation. , 1983, The Journal of investigative dermatology.
[184] S. Rastogi,et al. Lipid extraction and transport of hydrophilic solutes through porcine epidermis. , 2001, International journal of pharmaceutics.